Position in PFE
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$980,056
-$187,229 QoQ
Shares Held
40,700
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,340
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTH STAR ASSET MANAGEMENT INC holds $29,508,507 across 9 Drug Manufacturers - General names. PFE ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,325 | $13,583,545 | |
| 2 | JNJ |
Johnson & Johnson
|
28,155 | $7,150,524 | |
| 3 | AMGN |
Amgen Inc
|
10,471 | $3,791,758 | |
| 4 | NVO |
Novo Nordisk A S
|
40,676 | $1,950,007 | |
| 5 | PFE |
Pfizer Inc
This page
|
40,700 | $980,056 | |
| 6 | NVS |
Novartis AG
|
6,158 | $965,081 | |
| 7 | GSK |
GSK plc
|
8,108 | $425,021 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,161 | $412,615 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $980,056 | 40,700 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $1,167,285 | 41,570 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,084,693 | 43,562 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,307,633 | 51,320 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,342,241 | 55,373 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,543,560 | 60,914 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,699,219 | 64,049 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $2,300,787 | 79,502 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,394,864 | 85,592 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,143,270 | 113,271 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,615,707 | 125,589 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,408,823 | 132,916 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,042,509 | 137,473 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,765,937 | 141,322 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $7,357,449 | 143,588 | Shares | Sole | 2023-03-06 | |
| 2022-09-30 | $6,413,509 | 146,561 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,797,232 | 148,717 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $7,846,416 | 151,563 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $9,189,774 | 155,627 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,714,377 | 156,112 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,130,498 | 156,550 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $5,600,614 | 154,585 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $6,194,791 | 168,291 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,687,685 | 182,226 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $5,901,505 | 180,474 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $5,993,216 | 183,616 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||